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Abstract
Fabrication of stimuli-triggered drug delivery vehicle s is an important milestone in treating
cancer.  Here we demonstrate the selective anticancer drug delivery into human cells  with
biocompatible 50-nm diameter halloysite nanotube carriers. Physically-adsorbed dextrin end
stoppers secure the intercellular release of brilliant green. Drug-loaded nanotubes penetrate
through the cellular membranes and their uptake efficiency depends on the cells growth rate.
Intercellular  glycosyl  hydrolases-mediated  decomposition  of  the  dextrin  tube-end  stoppers
triggers the release of the lumen-loaded brilliant green, which allowed for preferable elimination
of human lung carcinoma cells (Crossed D sign 549) as compared with hepatoma cells (Hep3b).
The enzyme-activated intracellular delivery of brilliant green using dextrin-coated halloysite
nanotubes is a promising platform for anticancer treatment.
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